Which antibiotic class should be avoided for ESBL-producing organisms among the following options?

Prepare for the CAMLPR Microbiology Test. Utilize flashcards and engaging multiple-choice questions, each equipped with descriptions and explanations. Ready yourself for an excellent performance!

Multiple Choice

Which antibiotic class should be avoided for ESBL-producing organisms among the following options?

Explanation:
ESBL enzymes hydrolyze many beta-lactam antibiotics, including those in the cephalosporin family used in the third generation. Because these drugs are rapidly inactivated by ESBLs, infections caused by ESBL-producing organisms are typically resistant to third-generation cephalosporins, so they should be avoided. Carbapenems remain stable to ESBL hydrolysis and are usually effective, making them the preferred option when ESBL involvement is suspected or confirmed. Aminoglycosides and fluoroquinolones can be active against some ESBL producers, but resistance is common and they’re not as reliable for monotherapy; susceptibility testing is essential if they’re considered. In short, avoid third-generation cephalosporins for ESBL-producing infections and use a carbapenem when appropriate, with guidance from lab susceptibility data.

ESBL enzymes hydrolyze many beta-lactam antibiotics, including those in the cephalosporin family used in the third generation. Because these drugs are rapidly inactivated by ESBLs, infections caused by ESBL-producing organisms are typically resistant to third-generation cephalosporins, so they should be avoided. Carbapenems remain stable to ESBL hydrolysis and are usually effective, making them the preferred option when ESBL involvement is suspected or confirmed. Aminoglycosides and fluoroquinolones can be active against some ESBL producers, but resistance is common and they’re not as reliable for monotherapy; susceptibility testing is essential if they’re considered. In short, avoid third-generation cephalosporins for ESBL-producing infections and use a carbapenem when appropriate, with guidance from lab susceptibility data.